Showing results (291-300 of 310) with videos related to

Sort By:
Pageof 31
Liver Cancer|February 20, 2020
Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with LenvatinibAtsushi Hiraoka, Takashi Kumada, Shinya Fukunishi, et al.
European Journal of Gastroenterology & Hepatology|April 14, 2020
Platelet-lymphocyte ratio predicts survival in patients with hepatocellular carcinoma who receive lenvatinib: an inverse probability weighting analysisToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.
Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan|October 28, 2016
Interlaboratory Study on Volatiles Test for Food-Contacting Polystyrene ProductsHironori Sonobe, Motoh Mutsuga, Takashi Abe, et al.
Oncology|April 27, 2021
Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting AnalysisToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.
Liver Cancer|February 20, 2020
Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese PatientsMasaki Maeda, Issei Saeki, Isao Sakaida, et al.
Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan|May 11, 2018
[Interlaboratory Study on Evaporation Residue Test for Food Contact Products (Report 2)]Hiroyuki Ohno, Motoh Mutsuga, Tomoyuki Abe, et al.
Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan|May 11, 2018
[Interlaboratory Study on Evaporation Residue Test for Food Contact Products (Report 1)]Hiroyuki Ohno, Motoh Mutsuga, Tomoyuki Abe, et al.
Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan|December 28, 2016
Interlaboratory Study on Caprolactam Test for Food-Contact Nylon ProductsKazunari Watanabe, Motoh Mutsuga, Takashi Abe, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 18, 2020
Neutrophil-to-lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinibToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.
Gastroenterology Report|May 24, 2021
Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinomaAtsushi Hiraoka, Takashi Kumada, Toshifumi Tada, et al.
Pageof 31